Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1Genitourinary 1

Conditions

Multiple Myeloma 2Acute Kidney Injury 2Urinary Bladder Neoplasms 1Ureteral Neoplasms 1Paraproteinemias 1Nervous System Diseases 1Neoplasms, Plasma Cell 1Kidney Diseases 1Hematologic Diseases 1Autoimmune Diseases 1

Interventions

Cyclophosphamide 7fludarabine phosphate 4Flow Cytometry 4Busulfan 4Antilymphocyte Serum 4Tacrolimus 3Peripheral Blood Stem Cell Transplantation 3Mycophenolic Acid 3Whole-Body Irradiation 2Thiotepa 2Radiotherapy 2Methylprednisolone 2Methotrexate 2Melphalan 2Immunologic Techniques 2Filgrastim 2Etoposide 2Cyclosporine 2Carmustine 2Carboplatin 2Alemtuzumab 2thymoglobulin 1sargramostim 1resiquimod 1poly ICLC 1pazopanib 1orantinib 1motexafin gadolinium 1fludarabine 1dexamethasone acetate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Neoplasms, Plasma Cell × Plasma Exchange × Genitourinary × Clear all
NCT00120263 2025-03-25

Trial of Plasma Exchange for Acute Renal Failure at the Onset of Myeloma

London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's

Phase NA Completed
92 enrolled
GenitourinaryPlasma cell

Multiple Myeloma, Neoplasms, Plasma Cell, Acute Kidney Injury

Data powered by HemOnc (CC BY 4.0) Colophon âš¡